Three-dimensional echocardiography: in vitro and in vivo validation of left ventricular mass and comparison with conventional echocardiographic methods
AS Gopal,
AM Keller,
Z Shen,
PM Sapin,
KM Schroeder,
DL King Jr,
and
DL King
Columbia University, Division of Cardiology, New York, New York 10032.
OBJECTIVES. This study aimed to validate a method for mass computation in vitro and in vivo and to compare it with conventional methods. BACKGROUND. Conventional echocardiographic methods of determining left ventricular mass are limited by assumptions of ventricular geometry and image plane positioning. To improve accuracy, we developed a three-dimensional echocardiographic method that uses nonparallel, nonintersecting short-axis planes and a polyhedral surface reconstruction algorithm for mass computation. METHODS. Eleven fixed hearts were imaged by three-dimensional echocardiography, and mass was determined in vitro by multiplying the myocardial volume by the density of each heart and comparing it with the true mass. Mass at diastole and systole by three-dimensional echocardiography and magnetic resonance imaging (MRI) was compared in vivo in 15 normal subjects. Ten subjects also underwent imaging by one- and two-dimensional echocardiography, and mass was determined by Penn convention, area-length and truncated ellipsoid algorithms. RESULTS. In vitro results were r = 0.995, SEE 2.91 g, accuracy 3.47%. In vivo interobserver variability for systole and diastole was 16.7% to 27%, 14% to 18.1% and 6.3% to 12.8%, respectively, for one-, two- and three-dimensional echocardiography and was 7.5% for MRI at end-diastole. The latter two agreed closely with regard to diastolic mass (r = 0.895, SEE 11.1 g) and systolic mass (r = 0.926, SEE 9.2 g). These results were significantly better than correlations between MRI and the Penn convention (r = 0.725, SEE 25.6 g for diastole; r = 0.788, SEE 28.7 g for systole), area-length (r = 0.694, SEE 24.2 g for diastole; r = 0.717, SEE 28.2 g for systole) and truncated ellipsoid algorithms (r = 0.687, SEE 21.8 g for diastole; r = 0.710, SEE 24.5 g for systole). CONCLUSIONS. Image plane positioning guidance and elimination of geometric assumptions by three-dimensional echocardiography achieve high accuracy for left ventricular mass determination in vitro. It is associated with higher correlations and lower standard errors than conventional methods in vivo.
This article has been cited by other articles:

|
 |

|
 |
 
R. M. Lang, V. Mor-Avi, L. Sugeng, P. S. Nieman, and D. J. Sahn
Three-Dimensional Echocardiography: The Benefits of the Additional Dimension
J. Am. Coll. Cardiol.,
November 21, 2006;
48(10):
2053 - 2069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E G Caiani, C Corsi, L Sugeng, P MacEneaney, L Weinert, V Mor-Avi, and R M Lang
Improved quantification of left ventricular mass based on endocardial and epicardial surface detection with real time three dimensional echocardiography
Heart,
February 1, 2006;
92(2):
213 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Mor-Avi, L. Sugeng, L. Weinert, P. MacEneaney, E. G. Caiani, R. Koch, I. S. Salgo, and R. M. Lang
Fast Measurement of Left Ventricular Mass With Real-Time Three-Dimensional Echocardiography: Comparison With Magnetic Resonance Imaging
Circulation,
September 28, 2004;
110(13):
1814 - 1818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Sugeng, L Weinert, and R M Lang
Left ventricular assessment using real time three dimensional echocardiography
Heart,
November 1, 2003;
89(90003):
iii29 - 36.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.C. Vourvouri, D. Poldermans, A.F.L. Schinkel, L.Y. Koroleva, F.B. Sozzi, G.E. Parharidis, J.J. Bax, and J.R.T.C. Roelandt
Left ventricular hypertrophy screening using a hand-held ultrasound device
Eur. Heart J.,
October 1, 2002;
23(19):
1516 - 1521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Myerson, N. G. Bellenger, and D. J. Pennell
Assessment of Left Ventricular Mass by Cardiovascular Magnetic Resonance
Hypertension,
March 1, 2002;
39(3):
750 - 755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Sciacca, O. Akinboboye, R. Ling Chou, S. Epstein, and S. R. Bergmann
Measurement of Myocardial Blood Flow with PET Using 1-11C-Acetate
J. Nucl. Med.,
January 1, 2001;
42(1):
63 - 70.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. K. Louie and D. S. Louie
New Echocardiographic Technology: Does it Add to Clinical Decision-Making?
Seminars in Cardiothoracic and Vascular Anesthesia,
March 1, 1997;
1(1):
16 - 31.
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Sheps and E. D. Frohlich
Limited Echocardiography for Hypertensive Left Ventricular Hypertrophy
Hypertension,
February 1, 1997;
29(2):
560 - 563.
[Full Text]
|
 |
|

|
 |

|
 |
 
A. S. Gopal, Z. Shen, P. M. Sapin, A. M. Keller, M. J. Schnellbaecher, D. W. Leibowitz, O. O. Akinboboye, R. A. Rodney, D. K. Blood, and D. L. King
Assessment of Cardiac Function by Three-dimensional Echocardiography Compared With Conventional Noninvasive Methods
Circulation,
August 15, 1995;
92(4):
842 - 853.
[Abstract]
[Full Text]
|
 |
|
|